These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9708002)
21. The corporate practice of medicine doctrine: an anachronism in the modern health care industry. Chase-Lubitz JF Vanderbilt Law Rev; 1987 Mar; 40(2):445-88. PubMed ID: 11649888 [No Abstract] [Full Text] [Related]
22. [Marketing of the LIFE trial anticipates evaluation of the drug]. Järhult B Lakartidningen; 2002 Apr; 99(17):1964. PubMed ID: 12043424 [No Abstract] [Full Text] [Related]
23. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts. Brand R State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159 [No Abstract] [Full Text] [Related]
24. Prescription drug marketing: bribing health care workers? Margolis RE Healthspan; 1991 Jan; 8(1):18-20. PubMed ID: 10109337 [No Abstract] [Full Text] [Related]
25. Physicians, gifts and the pharmaceutical industry. Uzych L Nebr Med J; 1991 Sep; 76(9):311-2. PubMed ID: 1944698 [No Abstract] [Full Text] [Related]
26. Competition. Marketing your practice--how it can be ethical. Shahady EJ Consultant; 1987 Mar; 27(3):90-2. PubMed ID: 10289999 [TBL] [Abstract][Full Text] [Related]
27. Guidelines on gifts to physicians from industry: an update. American Medical Association. Council on Ethical and Judicial Affairs Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909 [No Abstract] [Full Text] [Related]
28. The debate of physician participation in capital punishment. Holmes DK N C Med J; 2007; 68(2):141. PubMed ID: 17571329 [No Abstract] [Full Text] [Related]
29. Regulating manufacturer-affiliated communication in the information age. Schulman KA; Abernethy DR; Rathore SS; Woosley RL Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664 [No Abstract] [Full Text] [Related]
30. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs. Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334 [No Abstract] [Full Text] [Related]
31. Ethical quandary. Smaller AMA moves slowly on rules for drug firms' influence over prescribing. Romano M Mod Healthc; 2001 Apr; 31(14):4-5, 14. PubMed ID: 11303424 [No Abstract] [Full Text] [Related]
34. Questions of ethics and performance arise for medical marketers in the 1990s. Longo B; Paris B J Hosp Mark; 1991; 6(1):29-35. PubMed ID: 10116635 [No Abstract] [Full Text] [Related]
35. Tough enough? Rules about drug firms' gifts get new look from docs. Romano M Mod Healthc; 2004 Jul; 34(27):16. PubMed ID: 15279115 [No Abstract] [Full Text] [Related]
36. Drug ads are no place for the doctor's face. Ingelfinger FJ N Engl J Med; 1973 Jul; 289(1):42-3. PubMed ID: 4708955 [No Abstract] [Full Text] [Related]
37. Sales reps: footsoldiers in drug company wars. Prescrire Int; 2004 Jun; 13(71):116. PubMed ID: 15233155 [No Abstract] [Full Text] [Related]
38. Men's health: the last great frontier. Weber DO Healthc Strateg; 1999 Oct; 3(10):1-8. PubMed ID: 10621159 [No Abstract] [Full Text] [Related]
39. Marketing that pulls. Gendusa J Mark Health Serv; 2008; 28(1):18-21. PubMed ID: 18389851 [No Abstract] [Full Text] [Related]